"The Effects of Oxytocin on Patients With Borderline Personality Disorder"
Status:
Active, not recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
RCT. Two substudies (clinical and experimental). Main objective of the trial is to examine if
oxytocin, compared to placebo shows any additional effect on the therapy achievements
(outcome) of patients with borderline personality disorder, who receive an in-patient
standard psychotherapy (Dialectical-behavioral-therapy, Marsha Linehan (2006)).
Secondary objectives :
Investigate if oxytocin compared to placebo enhances social trust and emotion recognition in
patients with borderline personality disorder. Comparison of the effects of Oxytocin on
patients with BPD and major depression.